Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × fludarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 66 Leukemia 63 Leukemia, Lymphocytic, Chronic, B-Cell 59 Myelodysplastic Syndromes 49 Lymphoma 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Lymphoma, Non-Hodgkin 41 Multiple Myeloma 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35 Hodgkin Disease 33 Melanoma 25 Hematologic Neoplasms 23 Myeloproliferative Disorders 16 Recurrence 15 Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Follicular 14 Primary Myelofibrosis 13 Lymphoma, Mantle-Cell 13 Neoplasms, Plasma Cell 12 Lymphoma, Large B-Cell, Diffuse 12 Skin Neoplasms 11 Graft vs Host Disease 10 Burkitt Lymphoma 10 Lymphoma, B-Cell, Marginal Zone 9 Anemia, Refractory, with Excess of Blasts 9 Lymphoma, B-Cell 8 Breast Neoplasms 8 Ovarian Neoplasms 7 Leukemia, Prolymphocytic 7

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 X-Rays 4 Phantoms, Imaging 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Carboplatin 3 Lapatinib 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 Biopsy 2 veliparib 1 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 palbociclib 1 olaparib 1 marizomib 1 larotrectinib 1 imetelstat 1 erdafitinib 1 dinutuximab 1 bempegaldesleukin 1 antineoplaston AS 2-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡